Abstract
Diagnosis of dilated cardiomyopathy (IDC) is a diagnosis of exclusion. Physical examination of the patient, non-invasive tests and invasive tests have to be done to exclude secondary dilated cardiomyopathies. Treatment can be divided into baseline therapy, established treatment, e.g. ACE-inhibitors, digitalis and diuretics and optional treatment including betablocker, anticoagulation and an natural course of IDC for an individual patient is not clear although there are several prognostic parameters for this disease.
MeSH terms
-
Angiotensin-Converting Enzyme Inhibitors / adverse effects
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Cardiomyopathy, Dilated / diagnosis
-
Cardiomyopathy, Dilated / drug therapy*
-
Cardiomyopathy, Dilated / etiology
-
Cardiovascular Agents / adverse effects
-
Cardiovascular Agents / therapeutic use*
-
Digitalis Glycosides / adverse effects
-
Digitalis Glycosides / therapeutic use
-
Diuretics / adverse effects
-
Diuretics / therapeutic use
-
Hemodynamics / drug effects
-
Humans
-
Prognosis
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Cardiovascular Agents
-
Digitalis Glycosides
-
Diuretics